查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1454802

静脉注射药物设备市场：依产品类型、最终用户、地区：全球产业分析、规模、占有率、成长、趋势、预测 2023-2030

IV Fluid Transfer Drug Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030
出版日期: | 出版商: Persistence Market Research | 英文 197 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 发布了一份关于全球静脉注射药物设备市场的富有洞察力的报告。这种全面的分析提供了对关键市场动态、市场驱动因素、课题和新兴趋势的宝贵见解。该报告详细概述了静脉注射药物器材产业，并提供了独家数据和统计数据，以预测 2023 年至 2030 年的市场成长轨迹。

全球静脉输液药物器材市场预计将以 3.5% 的复合年增长率成长，从 2023 年的 67 亿美元成长到 2030 年底的 85 亿美元。

重要见解

  • 静脉输注药物装置市场规模（2023年）：67亿美元
  • 预计市值（2030 年）：85 亿美元
  • 全球市场成长率（2023-2030年复合年增长率）：3.5%
  • 过去的市场成长率（2018-2022年复合年增长率）：2.3%

静脉注射药物器材市场：研究范围

由于慢性病的增加、对家庭医疗保健解决方案的需求不断增长以及药物输送技术的进步，静脉输注药物设备市场预计将显着增长。该市场为医疗机构、家庭护理机构和製药製造商提供各种专为安全、高效的给药而设计的静脉输注药物设备。人口老化、慢性病的增加以及远距医疗和远距患者监护服务的扩展正在推动市场成长。

市场驱动因素：

全球静脉注射药物设备市场受益于几个关键的市场驱动因素。癌症、糖尿病和心血管疾病等慢性疾病的盛行率不断上升、人口老化以及医疗保健支出的增加正在推动市场扩张。输液设备提供了给药的便利性、灵活性和准确性，提高了患者的依从性和治疗结果。此外，输液帮浦技术、智慧输液系统和穿戴式药物传输设备的进步使得个人化和连续的治疗监测成为可能。此外，家庭输液服务的扩张、特种药物的兴起以及基于价值的医疗保健模式的采用也正在影响市场。

市场限制因素：

儘管成长前景广阔，静脉注射药物器材市场仍面临监管合规、报销政策和病人安全等方面的课题。管理医疗器材设计、製造和销售的严格法规给製造商和医疗保健提供者带来了合规负担。此外，家庭输液治疗和特殊药物的报销有限可能会阻碍市场渗透。此外，对用药错误、药物交互作用和输液帮浦故障的担忧会影响病人安全和输液设备的可靠性。解决这些障碍需要行业利益相关者、监管机构和医疗保健支付者共同努力，确保患者获得安全有效的药物输送解决方案。

市场机会：

由于技术创新、人口趋势和不断发展的医疗保健服务模式，静脉注射药物设备市场呈现巨大的成长机会。无线连接、远端监控和智慧感测器等数位健康技术的整合将改善患者接受静脉治疗的机会，并提高治疗依从性和结果。此外，家庭输液服务、门诊输液中心和专业药房网路的扩张扩大了市场范围并刺激了创新。战略合作伙伴关係、研发投资以及推出易于使用、具有成本效益的药物输送设备对于利用新的商机并保持在动态静脉治疗市场的领先地位至关重要。

本报告解决的关键问题

  • 全球静脉输注药物设备市场的预期复合年增长率是多少？
  • 2023年市场规模有多大？
  • 2023年哪个国家将占据最大的市场占有率？
  • 谁是全球静脉输液药物器材市场的主要参与者？
  • 依应用划分，哪些市场成长最快？

目录

第一章执行摘要

第二章市场概况

  • 市场范围和定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 任务
    • 主要趋势
  • 应用程式生命週期分析
  • 静脉注射药物器材市场：价值链
    • 原材料供应商名单
    • 製造商名单
    • 经销商名单
    • 应用清单
    • 获利能力分析
  • 波特五力分析
  • 地缘政治紧张局势：对市场的影响
  • 宏观经济因素
    • 世界产业展望
    • 世界GDP成长率展望
    • 全球母公司市场概览
  • 预测变量 - 相关性和影响
  • 监管和技术格局

第三章全球静脉注射药物器材市场展望：实际（2018-2022）与预测（2023-2030）

  • 主要亮点
    • 市场容量（单位）预测
    • 市场规模及年成长率
    • 绝对的获利机会
  • 市场规模（百万美元）分析与预测
    • 过去的市场规模分析，2013-2016
    • 目前市场规模预测，2018-2026
  • 全球静脉注射药物器材市场展望：应用
    • 简介/主要发现
    • 2018-2022 年依应用划分的过去市场规模（百万美元）和数量（单位）分析
    • 2023-2030 年当前市场规模（百万美元）和依应用划分的数量（单位）预测
      • 自身免疫性疾病
      • 血液病
      • 心血管疾病
      • 神经病学
      • 肿瘤学
      • 其他
  • 市场吸引力分析：应用
  • 全球静脉注射药物设备市场展望：最终用户
    • 简介/主要发现
    • 2018-2022 年最终用户过去的市场规模（百万美元）和数量（单位）分析
    • 当前市场规模（百万美元）和最终用户预测数量（单位），2023-2030 年
      • 医院
      • 专科诊所
      • 其他
  • 市场吸引力分析：最终用户

第四章全球静脉注射药物器材市场展望：地区

  • 主要亮点
  • 2018-2022 年依地区历史市场规模（百万美元）及成交量（单位）分析
  • 2023-2030 年依地区划分的当前市场规模（百万美元）和预测数量（单位）
    • 北美
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲 (MEA)
  • 市场吸引力分析：区域

第五章北美 IV 输注药物器材市场展望：实际（2018-2022）与预测（2023-2030）

  • 主要亮点
  • 价格分析
  • 2018-2022 年依市场划分的过往市场规模（百万美元）和销售量（单位）分析
    • 依国家
    • 依用途
    • 依最终用户
  • 2023-2030 年各国目前市场规模（百万美元）及销售量（单位）预测
    • 美国
    • 加拿大
  • 2023-2030 年当前市场规模（百万美元）和依应用划分的数量（单位）预测
    • 自身免疫性疾病
    • 血液病
    • 心血管疾病
    • 神经病学
    • 肿瘤学
    • 其他
  • 当前市场规模（百万美元）和最终用户预测数量（单位），2023-2030 年
    • 医院
    • 专科诊所
    • 其他
  • 市场吸引力分析

第六章欧洲IV输注药物器材市场展望：实际（2018-2022）与预测（2023-2030）

  • 主要亮点
  • 价格分析
  • 2018-2022 年依市场划分的过往市场规模（百万美元）和销售量（单位）分析
    • 依国家
    • 依用途
    • 依最终用户
  • 2023-2030 年各国目前市场规模（百万美元）及销售量（单位）预测
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 土耳其
    • 欧洲其他地区
  • 2023-2030 年当前市场规模（百万美元）和依应用划分的数量（单位）预测
    • 自身免疫性疾病
    • 血液病
    • 心血管疾病
    • 神经病学
    • 肿瘤学
    • 其他
  • 当前市场规模（百万美元）和最终用户预测数量（单位），2023-2030 年
    • 医院
    • 专科诊所
    • 其他
  • 市场吸引力分析

第七章东亚IV输注药物器材市场展望：实际（2018-2022）与预测（2023-2030）

  • 主要亮点
  • 价格分析
  • 2018-2022 年依市场划分的过往市场规模（百万美元）和销售量（单位）分析
    • 依国家
    • 依用途
    • 依最终用户
  • 2023-2030 年各国目前市场规模（百万美元）及销售量（单位）预测
    • 中国
    • 日本
    • 韩国
  • 2023-2030 年当前市场规模（百万美元）和依应用划分的数量（单位）预测
    • 自身免疫性疾病
    • 血液病
    • 心血管疾病
    • 神经病学
    • 肿瘤学
    • 其他
  • 当前市场规模（百万美元）和最终用户预测数量（单位），2023-2030 年
    • 医院
    • 专科诊所
    • 其他
  • 市场吸引力分析

第八章南亚和大洋洲 IV 输注药物器械市场展望：实际（2018-2022）和预测（2023-2030）

  • 主要亮点
  • 价格分析
  • 2018-2022 年依市场划分的过往市场规模（百万美元）和销售量（单位）分析
    • 依国家
    • 依用途
    • 依最终用户
  • 2023-2030 年各国目前市场规模（百万美元）及销售量（单位）预测
    • 印度
    • 东南亚
    • 纽西兰
    • 南亚和大洋洲其他地区
  • 2023-2030 年当前市场规模（百万美元）和依应用划分的数量（单位）预测
    • 自身免疫性疾病
    • 血液病
    • 心血管疾病
    • 神经病学
    • 肿瘤学
    • 其他
  • 当前市场规模（百万美元）和最终用户预测数量（单位），2023-2030 年
    • 医院
    • 专科诊所
    • 其他
  • 市场吸引力分析

第9章拉丁美洲IV输注药物器械市场展望：实际（2018-2022）与预测（2023-2030）

  • 主要亮点
  • 价格分析
  • 2018-2022 年依市场划分的过往市场规模（百万美元）和销售量（单位）分析
    • 依国家
    • 依用途
    • 依最终用户
  • 2023-2030 年各国目前市场规模（百万美元）及销售量（单位）预测
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 2023-2030 年当前市场规模（百万美元）和依应用划分的数量（单位）预测
    • 自身免疫性疾病
    • 血液病
    • 心血管疾病
    • 神经病学
    • 肿瘤学
    • 其他
  • 当前市场规模（百万美元）和最终用户预测数量（单位），2023-2030 年
    • 医院
    • 专科诊所
    • 其他
  • 市场吸引力分析

第10章中东和非洲IV输注药物器械市场展望：实际（2018-2022）和预测（2023-2030）

  • 主要亮点
  • 价格分析
  • 2018-2022 年过去的市场规模（百万美元）与市场销售（单位）分析
    • 依国家
    • 依用途
    • 依最终用户
  • 2023-2030 年各国目前市场规模（百万美元）及销售量（单位）预测
    • 海湾合作委员会
    • 埃及
    • 南非
    • 北非
    • 其他中东和非洲
  • 2023-2030 年当前市场规模（百万美元）和依应用划分的数量（单位）预测
    • 自身免疫性疾病
    • 血液病
    • 心血管疾病
    • 神经病学
    • 肿瘤学
    • 其他
  • 当前市场规模（百万美元）和最终用户预测数量（单位），2023-2030 年
    • 医院
    • 专科诊所
    • 其他
  • 市场吸引力分析

第十一章竞争格局

  • 2022 年市场占有率分析
  • 市场结构
    • 依市场划分的竞争强度图
    • 比赛仪表板
    • 表观应用能力
  • 公司简介（详细资讯 - 概述、财务、策略、近期发展）
    • Advance Medical Designs Inc.
    • B. Braun Medical
    • Baxter Healthcare
    • ICU Medical Inc.
    • Hospira
    • QI Medical Inc.
    • Pfizer
    • Unilife Corporation
    • Amedra Pharmaceuticals
    • Sanofi
    • Biogen Idec
    • BIONIK Laboratories Corp.
    • Ekso Bionics Holdings Inc.

第十二章附录

  • 调查方法
  • 调查假设
  • 缩写
简介目录
Product Code: PMRREP33966

Persistence Market Research, a renowned market research firm, has recently released an insightful report on the global IV Fluid Transfer Drug Devices Market. This comprehensive analysis offers valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. The report provides a detailed overview of the IV fluid transfer drug devices industry, featuring exclusive data and statistics projecting the market's growth trajectory from 2023 to 2030.

The global IV fluid transfer drug devices market is forecast to expand at a CAGR of 3.5% and thereby increase from a value of US$6.7 Bn in 2023, to US$8.5 Bn by the end of 2030.

Key Insights:

  • IV Fluid Transfer Drug Devices Market Size (2023): US$6.7 Bn
  • Projected Market Value (2030): US$8.5 Bn
  • Global Market Growth Rate (CAGR 2023 to 2030): 3.5%
  • Historical Market Growth Rate (CAGR 2018 to 2022): 2.3%

IV Fluid Transfer Drug Devices Market - Report Scope:

The IV Fluid Transfer Drug Devices Market is poised for significant growth, driven by the increasing prevalence of chronic diseases, the rising demand for home healthcare solutions, and advancements in drug delivery technologies. This market serves healthcare institutions, homecare settings, and pharmaceutical manufacturers, offering a range of IV fluid transfer devices designed for safe and efficient drug administration. Market growth is fueled by the aging population, the growing incidence of chronic conditions, and the expansion of telemedicine and remote patient monitoring services.

Market Growth Drivers:

The global IV Fluid Transfer Drug Devices Market benefits from several key growth drivers. The growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, coupled with the aging population and increasing healthcare expenditure, drives market expansion. IV fluid transfer devices offer convenience, flexibility, and accuracy in drug administration, enhancing patient compliance and treatment outcomes. Moreover, advancements in infusion pump technologies, smart infusion systems, and wearable drug delivery devices enable personalized and continuous therapy monitoring. The market is also influenced by the expansion of home infusion services, the rise of specialty pharmaceuticals, and the adoption of value-based healthcare models.

Market Restraints:

Despite promising growth prospects, the IV Fluid Transfer Drug Devices Market faces challenges related to regulatory compliance, reimbursement policies, and patient safety concerns. Stringent regulations governing the design, manufacturing, and marketing of medical devices impose compliance burdens on manufacturers and healthcare providers. Additionally, reimbursement limitations for home infusion therapy and specialty drugs may hinder market penetration. Furthermore, concerns related to medication errors, drug interactions, and infusion pump malfunctions impact patient safety and trust in IV fluid transfer devices. Addressing these barriers requires collaboration between industry stakeholders, regulatory authorities, and healthcare payers to ensure patient access to safe and effective drug delivery solutions.

Market Opportunities:

The IV Fluid Transfer Drug Devices Market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as wireless connectivity, remote monitoring, and smart sensors, enhances patient access to IV therapy and improves treatment adherence and outcomes. Furthermore, the expansion of home infusion services, ambulatory infusion centers, and specialty pharmacy networks broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of user-friendly, cost-effective drug delivery devices are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic landscape of IV therapy.

Key Questions Answered in the Report:

  • What is the Forecast CAGR of the Global IV Fluid Transfer Drug Devices Market?
  • What was the Market Size in the Year 2023?
  • Which Country Held the Largest Market Share in 2023?
  • Who are the Key Players in the Global IV Fluid Transfer Drug Devices Market?
  • Which is the Fastest-growing Segment of the Market by Application?

Competitive Intelligence and Business Strategy:

Leading players in the global IV Fluid Transfer Drug Devices Market, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in the development of advanced infusion pumps, drug delivery systems, and infusion sets, exploring novel materials and wireless connectivity options to enhance device functionality and user experience. Collaborations with healthcare providers, home infusion companies, and specialty pharmacies facilitate market access and improve the adoption of IV fluid transfer devices. Moreover, emphasis on patient education, training programs, and 24/7 technical support services fosters market growth and enhances patient safety in the rapidly evolving landscape of home infusion therapy and specialty drug administration.

Key Companies Profiled:

  • Advance Medical Designs Inc.
  • B. Braun Medical
  • Baxter Healthcare
  • ICU Medical Inc.
  • Hospira
  • Q.I. Medical Inc.
  • Pfizer
  • Unilife Corporation
  • Amedra Pharmaceuticals
  • Sanofi
  • Biogen Idec
  • BIONIK Laboratories Corp.
  • Ekso Bionics Holdings Inc.

IV Fluid Transfer Drug Devices Market Research Segmentation:

Oncology stands out as the leading application driving global market growth in IV fluid transfer drug devices. The significant increase in the oncology category is attributed to the rising incidence of cancer and the growing use of intravenous chemotherapy treatments, where IV fluid transfer devices play a crucial role in delivering accurate dosages.

The fastest-growing market segment is neurology, fueled by the increasing prevalence of neurological illnesses worldwide. The demand for intravenous therapies in neurology, including drug administration for conditions such as neuropathic pain and multiple sclerosis, drives the rapid rise of this market sector.

Hospitals dominate the end-user segment due to their large patient volumes, diverse medical needs, and the essential role IV treatments play in acute and critical care settings. Specialist clinics represent the fastest-growing market category, driven by the rise in outpatient care and the demand for focused and customized treatments.

North America maintains dominance in the IV fluid transfer drug devices market, driven by its advanced healthcare technologies, substantial healthcare expenditure, and strong regulatory framework. The region's proactive adoption of cutting-edge healthcare technologies and the increasing prevalence of chronic diseases contribute to the high demand for IV fluid transfer devices. In contrast, the IV fluid transfer drug devices market is expanding rapidly in East Asia, propelled by rapid economic development, rising healthcare awareness, and a growing demand for advanced medical treatments in countries like China, Japan, and South Korea.

By Application:

  • Autoimmune Diseases
  • Blood Disorders
  • Cardiovascular Disorders
  • Neurology
  • Oncology
  • Others

By End User:

  • Hospitals
  • Specialized Clinics
  • Others

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global IV Fluid Transfer Drug Devices Market Snapshot, 2023 and 2030
  • 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Application Lifecycle Analysis
  • 2.4. IV Fluid Transfer Drug Devices Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2013-2016
    • 3.2.2. Current Market Size Forecast, 2018-2026
  • 3.3. Global IV Fluid Transfer Drug Devices Market Outlook: Application
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
      • 3.3.3.1. Autoimmune Diseases
      • 3.3.3.2. Blood Disorders
      • 3.3.3.3. Cardiovascular Disorders
      • 3.3.3.4. Neurology
      • 3.3.3.5. Oncology
      • 3.3.3.6. Others
  • 3.4. Market Attractiveness Analysis: Application
  • 3.5. Global IV Fluid Transfer Drug Devices Market Outlook: End User
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
      • 3.5.3.1. Hospitals
      • 3.5.3.2. Specialized Clinics
      • 3.5.3.3. Others
  • 3.6. Market Attractiveness Analysis: End User

4. Global IV Fluid Transfer Drug Devices Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 5.3.1. By Country
    • 5.3.2. By Application
    • 5.3.3. By End User
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 5.5.1. Autoimmune Diseases
    • 5.5.2. Blood Disorders
    • 5.5.3. Cardiovascular Disorders
    • 5.5.4. Neurology
    • 5.5.5. Oncology
    • 5.5.6. Others
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 5.6.1. Hospitals
    • 5.6.2. Specialized Clinics
    • 5.6.3. Others
  • 5.7. Market Attractiveness Analysis

6. Europe IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 6.3.1. By Country
    • 6.3.2. By Application
    • 6.3.3. By End User
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkiye
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 6.5.1. Autoimmune Diseases
    • 6.5.2. Blood Disorders
    • 6.5.3. Cardiovascular Disorders
    • 6.5.4. Neurology
    • 6.5.5. Oncology
    • 6.5.6. Others
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 6.6.1. Hospitals
    • 6.6.2. Specialized Clinics
    • 6.6.3. Others
  • 6.7. Market Attractiveness Analysis

7. East Asia IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 7.3.1. By Country
    • 7.3.2. By Application
    • 7.3.3. By End User
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 7.5.1. Autoimmune Diseases
    • 7.5.2. Blood Disorders
    • 7.5.3. Cardiovascular Disorders
    • 7.5.4. Neurology
    • 7.5.5. Oncology
    • 7.5.6. Others
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 7.6.1. Hospitals
    • 7.6.2. Specialized Clinics
    • 7.6.3. Others
  • 7.7. Market Attractiveness Analysis

8. South Asia & Oceania IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 8.3.1. By Country
    • 8.3.2. By Application
    • 8.3.3. By End User
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 8.5.1. Autoimmune Diseases
    • 8.5.2. Blood Disorders
    • 8.5.3. Cardiovascular Disorders
    • 8.5.4. Neurology
    • 8.5.5. Oncology
    • 8.5.6. Others
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 8.6.1. Hospitals
    • 8.6.2. Specialized Clinics
    • 8.6.3. Others
  • 8.7. Market Attractiveness Analysis

9. Latin America IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 9.3.1. By Country
    • 9.3.2. By Application
    • 9.3.3. By End User
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 9.5.1. Autoimmune Diseases
    • 9.5.2. Blood Disorders
    • 9.5.3. Cardiovascular Disorders
    • 9.5.4. Neurology
    • 9.5.5. Oncology
    • 9.5.6. Others
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 9.6.1. Hospitals
    • 9.6.2. Specialized Clinics
    • 9.6.3. Others
  • 9.7. Market Attractiveness Analysis

10. Middle East & Africa IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 10.3.1. By Country
    • 10.3.2. By Application
    • 10.3.3. By End User
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 10.5.1. Autoimmune Diseases
    • 10.5.2. Blood Disorders
    • 10.5.3. Cardiovascular Disorders
    • 10.5.4. Neurology
    • 10.5.5. Oncology
    • 10.5.6. Others
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 10.6.1. Hospitals
    • 10.6.2. Specialized Clinics
    • 10.6.3. Others
  • 10.7. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2022
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Dashboard
    • 11.2.3. Apparent Application Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Advance Medical Designs Inc.
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Application
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. B. Braun Medical
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Application
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Baxter Healthcare
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Application
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. ICU Medical Inc.
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Application
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Hospira
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Application
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. Q.I. Medical Inc.
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Application
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Pfizer
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Application
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Unilife Corporation
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Application
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Amedra Pharmaceuticals
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Application
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Sanofi
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Application
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. Biogen Idec
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Application
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy
    • 11.3.12. BIONIK Laboratories Corp.
      • 11.3.12.1. Overview
      • 11.3.12.2. Segments and Application
      • 11.3.12.3. Key Financials
      • 11.3.12.4. Market Developments
      • 11.3.12.5. Market Strategy
    • 11.3.13. Ekso Bionics Holdings Inc.
      • 11.3.13.1. Overview
      • 11.3.13.2. Segments and Application
      • 11.3.13.3. Key Financials
      • 11.3.13.4. Market Developments
      • 11.3.13.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations